BioSpace examines the busiest corporate venture capital arms in the pharmaceutical industry. Novo Holdings, which made ...

SK bioscience, a biotech arm of Korea's SK Group, said Wednesday it has won a patent lawsuit against global pharmaceutical ...

Pfizer shares climbed Tuesday after two punchy headlines hit the wire. FDA advisors are considering COVID-19 vaccines for ...

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...

COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift ...

The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using ...

Novavax's shot is now fully approved in the U.S. Since 2022, the vaccine has been used under an emergency use authorization. Health experts consider it a valuable alternative to messenger RNA shots ...

L+M Development nabbed a $36.9M mortgage from Lument for its 91-unit rental project at 235 Central Park N. in Harlem, ...

The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...

COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration.

Jeffrey Casberg, M.S., vice president of clinical pharmacy at IPD Analytics, shared his insights on the results of Managed Healthcare Executive’s annual Pharmacy Survey in this part-two interview of a ...